In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant acinetobacter baumannii, including colistin- or tigecycline-resistant isolates

Kyong Ran Peck, Min Ja Kim, Ji Young Choi, Hong Sun Kim, Cheol In Kang, Yong Kyun Cho, Dae Won Park, Hee Joo Lee, Mi Suk Lee, Kwan Soo Ko

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The emergence of colistin or tigecycline resistance as well as imipenem resistance in Acinetobacter baumannii poses a great therapeutic challenge. The bactericidal and synergistic effects of several combinations of antimicrobial agents against imipenem-, colistin- or tigecycline-resistant A. baumannii isolates were investigated by in vitro time-kill experiments. Six imipenem-resistant A. baumannii blood isolates were examined in this study, including colistin- and tigecycline-susceptible, colistin-resistant but tigecycline-susceptible, and colistin-susceptible but tigecycline-resistant isolates. Time-kill studies were performed using five antimicrobial agents singly or in combinations (imipenem plus colistin, imipenem plus ampicillin-sulbactam, colistin plus rifampicin, colistin plus tigecycline, and tigecycline plus rifampicin) at concentrations of 0.5x and 1 x their MICs. Only imipenem was consistently effective as a single agent against all six A. baumannii isolates. Although the effectiveness of combinations of 0.5x MIC antimicrobial agents was inconsistent, combination regimens using 1 x MIC of the antimicrobial agents displayed excellent bactericidal activities against all six A. baumannii isolates. Among the combinations of 0.5x MIC antimicrobial agents, the combination of colistin and tigecycline showed synergistic or bactericidal effects against four of the isolates. This in vitro time-kill analysis suggests that antimicrobial combinations are effective for killing imipenem-resistant A. baumannii isolates, even if they are simultaneously resistant to either colistin or tigecycline. However, the finding that the combinations of 0.5x MIC antimicrobial agents were effective on only some isolates may warrant further investigation of the doses of combination agents needed to kill resistant A. baumannii.

Original languageEnglish
Pages (from-to)353-360
Number of pages8
JournalJournal of Medical Microbiology
Volume61
Issue number3
DOIs
Publication statusPublished - 2012 Mar

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant acinetobacter baumannii, including colistin- or tigecycline-resistant isolates'. Together they form a unique fingerprint.

  • Cite this